Search result for INmune Bio
Alzheimer’s Disease related trial announced by INmune Bio, Inc.
The usage of Phase Ib clinical trials for Alzheimer patients were announced by INmune Bio, Inc. (NASDAQ: INMB), a company specializing in immunology which utilizes the patients’ immune system to fend off disease. The purpose of the trail is to test the use and safety of a brand new anti-inf...